Presentation

Academic

  • Introduction to cells of the immune system: Nutrition Research Center grand rounds (09/2024)

Other

  • A patient-derived ovarian cancer model of platinum resistance: OB/Gyn research day (05/2024)
  • Graduate studies in the school of medicine. Open House (01/2025)

Research

  • CHDMM Chalk Talk: Cell Fate Decisions in Cancer: The epithelial-mesenchymal transition factor Snail inhibits the tumor suppressor microRNA let-7 (03/2016)
  • Cancer RIP: The epithelial-mesenchymal transition and Cancer Stem Cells: The EMT factor Snail inhibits the tumor suppressor microRNA let-7 (04/2016)
  • Pathology Grand Rounds: The epithelial-mesenchymal transition and Cancer Stem Cells: The EMT factor Snail inhibits the tumor suppressor microRNA let-7 (04/2016)
  • Cedars-Sinai: The epithelial-mesenchymal transition and Cancer Stem Cells: The EMT factor Snail inhibits the tumor suppressor microRNA let-7 (07/2016)
  • miRNA let-7 in Cancer and Development: Targeting Ovarian Cancer Stem Cells to Prevent Recurrence (11/2018 - 04/2019)
  • Patient-derived Ovarian Cancer Cells for Targeting Stemness via the Snail / let-7 axis (11/2019)
  • Targeting Ovarian Cancer Stem Cells to prevent recurrence:  Snail is associated with stemness and represses let-7  (03/2020)
  • Targeting Ovarian Cancer Stem Cells to prevent recurrence: Snail is associated with stemness and represses let-7   Cancer Research Program Meeting (03/2020)
  • Targeting Ovarian Cancer Stem Cells to prevent recurrence: Snail is associated with stemness and represses let-7 (03/2020)
  • The epithelial-mesenchymal transcription factor SNAI1 represses transcription of the tumor suppressor miRNA let-7 in cancer CHDMM - Chalk Talk (11/2020)
  • The epithelial-mesenchymal transcription factor SNAI1 represses transcription of the tumor suppressor miRNA let-7 in cancer  (11/2020)
  • The epithelial-mesenchymal transcription factor SNAI1 represses transcription of the tumor suppressor miRNA let-7 in cancer  (11/2020)
  • Ovarian Cancer Health Disparities: Targeting ovarian cancer stem cells CHDMM (04/2021)
  • Ovarian Cancer Health Disparities (04/2021)
  • Targeting Ovarian Cancer Stem Cells via the Snail/let-7 axis (07/2021)
  • Targeting Ovarian Cancer Stem Cells via the Snail/let-7 Axis Chalk Talk (11/2021)
  • Targeting Ovarian Cancer Stem Cells via the Snail/let-7 Axis (11/2021)
  • Targeting Ovarian Cancer Stem cells via the Snail/let-7 Axis. Gynecology/Obstetrics Grand Rounds (01/2022)
  • Targeting Ovarian Cancer Stem Cells via the Snail/let-7 Axis Gynecology/Obstetrics Grand Rounds (01/2022)
  • Cancer cell aggressiveness caused by conventional vs. proton irradiation Cancer Research in Progress (09/2022)
  • Cancer cell aggressiveness caused by conventional vs. proton irradiation Chalk Talk CHDMM (10/2022)
  • Genetic testing in the LatinX community: impact of acculturation and provider characteristics: Chalk Talk (10/2023)
  • A patient-derived ovarian cancer model of platinum resistance: Chalk talk (04/2024)
  • Interferon type I signaling and platinum resistance in a patient-derived model of ovarian cancer: Chalk talk (11/2024)
  • Stemness, EMT, and chemoresistance: not always hand in hand. IESCC Symposium (11/2024)